Japanese Pharma Co. Beats Bid To Nix Drug Patent At EPO
The European Patent Office's disputes board has rejected calls to revoke a Japanese pharmaceutical company's patent for the dosage of its anti-cancer drug, tossing claims from two rival drugmakers that the invention...To view the full article, register now.
Already a subscriber? Click here to view full article